Prevalence of Alloimmunization and Associated Risk Factors among Antenatal Women in India: A Systematic Review and Meta-Analysis
Transfusion Medicine and Hemotherapy · 25.08.2025 · 52 (5) · 304-317
DOI: 10.1159/000548072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transfusion Medicine and Hemotherapy, online erschienen am 25.08.2025. Verfasst von Shamee Shastry und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunohematology and Blood Transfusion, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Maternal alloimmunization can lead to significant perinatal morbidity and mortality. The rate of maternal alloimmunization reported is varied across the studies conducted in India. A systematic review will help in understanding the overall prevalence of alloimmunization. Additionally, the study aimed at understanding the factors affecting the rate of maternal alloimmunization.
Methods
A search of original articles reporting rate of alloimmunization among antenatal women published in English language from India was performed in Scopus, Google Scholar, MEDLINE, and CINAHL databases. Two independent teams, each comprising two reviewers, extracted data from the eligible studies. Meta-analysis was performed for cumulative estimates by binary random-effects model using the restricted maximum likelihood method.
Results
Fourteen studies published between 2011 and 2023 were included. The pooled prevalence of maternal alloimmunization was 2.0 per 100 (95% CI: 1.5–2.5) among antenatal women, with significant heterogeneity across studies. Anti-D was the most frequently identified antibody (56.39%), followed by anti-D + anti-C (10.68%) and anti-E (5.71%). Higher risk of alloimmunization was observed in women with Rhesus D-negative blood group, multigravida status, history of blood transfusion, and bad obstetric history.
Conclusion
Despite the availability of anti-D prophylaxis, over half of the alloimmunized women had anti-D antibodies, indicating potential gaps in prevention strategies. Further research is needed to understand these gaps and implement effective interventions to minimize this preventable cause of fetal and neonatal complications. For girls and women of reproductive age, providing prohylactic antigen-matched (Rh and Kell) red cell units when transfusion is needed may reduce the burden of red cell alloimmunization.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunohematology and Blood Transfusion, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India.
- Department of Transfusion Medicine, All India Institute of Medical Sciences, Nagpur, India.
- Sri Chitra Tirunal Institute of Medical Sciences and Technology, Trivandrum, India.
- Department of Transfusion Medicine, Malabar Cancer Centre - Postgraduate Institute of Oncology Sciences and Research, Thalassery, India.
- Department of Transfusion Medicine, Hind Institute of Medical Sciences, Barabanki, India.
Zitieren
APA
Shastry, S., Chenna, D., Das, S., Rajendran, V., Murugesan, M., & Chaudhary, R. (2025). Prevalence of Alloimmunization and Associated Risk Factors among Antenatal Women in India: A Systematic Review and Meta-Analysis. Transfusion Medicine and Hemotherapy, 52(5), 304-317. https://doi.org/10.1159/000548072
Vancouver
Shastry S, Chenna D, Das S, Rajendran V, Murugesan M, Chaudhary R. Prevalence of Alloimmunization and Associated Risk Factors among Antenatal Women in India: A Systematic Review and Meta-Analysis. Transfusion Medicine and Hemotherapy. 2025;52(5):304-317. doi:10.1159/000548072
BibTeX
@article{Shastry2025,
author = {Shastry, Shamee and Chenna, Deepika and Das, Soumya and Rajendran, Vinu and Murugesan, Mohandoss and Chaudhary, Rajendra},
title = {Prevalence of Alloimmunization and Associated Risk Factors among Antenatal Women in India: A Systematic Review and Meta-Analysis},
journal = {Transfusion Medicine and Hemotherapy},
year = {2025},
volume = {52},
number = {5},
pages = {304--317},
doi = {10.1159/000548072}
}
EUVIMED